^
    Apply
    A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets (TQA3334-Ⅰ-02) (NCT04273815)
    Phase 1/2
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Recruiting
    Last update posted :
    07/08/2020
    Initiation :
    07/06/2020
    Primary completion :
    01/31/2021
    Completion :
    01/31/2021
    EGFR • ALK
    |
    ALK positive
    |
    Focus V (anlotinib) • AL-034